Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology


Gumusay O., Coskun U., AKMAN T., EKINCI A. S. , Kocar M., ERCELEB O. B. , ...More

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.140, no.1, pp.151-157, 2014 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 140 Issue: 1
  • Publication Date: 2014
  • Doi Number: 10.1007/s00432-013-1553-7
  • Title of Journal : JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • Page Numbers: pp.151-157

Abstract

The development of brain metastases (BMs) was associated with poor prognosis in melanoma patients. Patients with BMs have a median survival of < 6 months. Melanoma is the third most common tumor to metastasize to the brain with a reported incidence of 10-40 %. Our aim was to identify factors predicting development of BMs and survival.